Item 5.07. Submission of Matters to a Vote of Security Holders.
The 2016 Annual Meeting of Stockholders (the
Annual Meeting
) of Rigel Pharmaceuticals, Inc. (the
Company
) was held on May 10, 2016. The following is a brief description of each matter voted upon at the Annual Meeting, as well as the number of votes cast for or against each matter and the number of abstentions and broker non-votes with respect to each matter. A more complete description of each matter is set forth in the Companys definitive proxy statement for the Annual Meeting filed with the Securities and Exchange Commission (the
SEC
) on March 28, 2016 and the Companys supplement to proxy statement filed with the SEC on May 3, 2016.
·
Each of the three nominees for director, to serve until the Companys 2019 Annual Meeting of Stockholders or until his respective successor has been elected and qualified, was elected as follows:
Nominee
|
|
Shares
Voted For
|
|
Shares
Withheld
|
|
Peter S. Ringrose, Ph.D.
|
|
61,496,500
|
|
731,689
|
|
Bradford S. Goodwin
|
|
61,402,512
|
|
825,677
|
|
Keith A Katkin
|
|
61,407,599
|
|
820,590
|
|
There were 17,736,557 broker non-votes for this matter.
·
The Companys stockholders approved the Companys 2011 Equity Incentive Plan, as amended.
The tabulation of votes on this matter was as follows: shares voted for: 56,675,097; shares voted against: 5,480,745; shares abstaining: 72,347; and broker non-votes: 17,736,557.
·
The Companys stockholders approved the Companys 2000 Non-Employee Directors Stock Option Plan, as amended.
The tabulation of votes on this matter was as follows: shares voted for: 47,554,882; shares voted against: 14,609,427; shares abstaining: 63,880; and broker non-votes: 17,736,557.
·
The Companys stockholders approved, on an advisory basis, the compensation of the Companys named executive officers.
The tabulation of votes on this matter was as follows: shares voted for: 43,686,874; shares voted against: 18,486,245; shares abstaining: 55,070; and broker non-votes: 17,736,557.
·
The Companys stockholders ratified the selection of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2016.
The tabulation of votes on this matter was as follows: shares voted for: 74,772,665; shares voted against: 5,037,609; shares abstaining: 154,472.
2